Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) Net Income From Continuing Operations : ₫0.00 Mil (TTM As of . 20)

View and export this data going back to 2019. Start your Free Trial

What is Pharbaco Central Pharmaceutical JSC No 1 Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Pharbaco Central Pharmaceutical JSC No 1's net income from continuing operations for the six months ended in . 20 was ₫0.00 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

Pharbaco Central Pharmaceutical JSC No 1 Net Income From Continuing Operations Historical Data

The historical data trend for Pharbaco Central Pharmaceutical JSC No 1's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharbaco Central Pharmaceutical JSC No 1 Net Income From Continuing Operations Chart

Pharbaco Central Pharmaceutical JSC No 1 Annual Data

Trend

Net Income From Continuing Operations

Pharbaco Central Pharmaceutical JSC No 1 Semi-Annual Data

Net Income From Continuing Operations

Pharbaco Central Pharmaceutical JSC No 1 Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income From Continuing Operations for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

160 Ton Duc Thang, Hang Bot ward, Dong Da District, Hanoi, VNM

Website

https://www.pharbaco.com.vn

Pharbaco Central Pharmaceutical JSC No 1 is a pharmaceutical company. Some of its products include Cefadroxil 250mg, Elnizol infusion drug, and Fabafixim 50.

Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) Headlines

No Headlines